| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.45B | 20.50B | 20.72B | 21.20B | 19.97B | 10.85B |
| Gross Profit | 3.90B | 4.63B | 3.87B | 6.01B | 7.65B | 4.16B |
| EBITDA | 150.00K | 488.00M | 645.40M | 2.16B | 4.52B | 2.28B |
| Net Income | -1.11B | -461.00M | -387.90M | 898.30M | 2.81B | 1.18B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 38.07B | 33.20B | 23.60B | 18.62B | 13.43B |
| Cash, Cash Equivalents and Short-Term Investments | 1.83B | 1.86B | 4.49B | 4.59B | 5.54B | 3.25B |
| Total Debt | 0.00 | 17.86B | 12.52B | 5.14B | 1.65B | 1.83B |
| Total Liabilities | -11.56B | 26.51B | 21.74B | 11.68B | 7.77B | 5.40B |
| Stockholders Equity | 11.56B | 11.56B | 11.46B | 11.92B | 10.85B | 8.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.79B | -5.74B | -3.09B | 3.29B | 1.60B |
| Operating Cash Flow | 0.00 | -658.80M | 2.37B | 541.30M | 4.02B | 2.21B |
| Investing Cash Flow | 0.00 | -5.42B | -8.31B | -3.59B | -1.39B | -1.57B |
| Financing Cash Flow | 0.00 | 3.75B | 6.43B | 2.06B | -699.80M | -379.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹26.65B | 27.17 | ― | 0.65% | -10.12% | -22.38% | |
64 Neutral | ₹13.49B | 25.80 | ― | 0.24% | 10.70% | 32.65% | |
64 Neutral | ₹29.76B | 167.79 | ― | 0.07% | 16.88% | 0.69% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹23.02B | 19.87 | ― | 0.97% | 5.74% | 16.06% | |
59 Neutral | ₹11.73B | 36.09 | ― | 2.59% | -10.71% | -40.89% | |
41 Neutral | ₹25.90B | -15.15 | ― | 0.43% | -11.11% | -340.74% |
Thirumalai Chemicals Limited has notified the stock exchanges that it has received a confirmation certificate from its Registrar and Transfer Agent, MUFG Intime India Private Limited, for the quarter ended 31 December 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The registrar confirmed that all securities lodged for dematerialisation during the quarter were duly processed, accepted or rejected as appropriate, listed on the relevant stock exchanges, and that the corresponding physical certificates were cancelled and replaced in the company’s register of members within prescribed timelines, underscoring the company’s adherence to regulatory requirements in handling its dematerialised securities.
Thirumalai Chemicals Limited has announced that its step-down wholly owned U.S. subsidiary, TCL Specialties LLC, has commenced the first phase of commercial operations at its new manufacturing facility with the initial sale of Maleic Anhydride. The US plant, which houses a 40,500 tonnes per annum Maleic Anhydride unit and a 30,000 tonnes per annum food ingredients unit for malic and fumaric acids, is undergoing phased commissioning expected to be completed and stabilized in the first half of 2026, positioning the company to serve currently underserved Maleic Anhydride markets in the North-Eastern and Mid-West United States and strengthening its presence in high-growth applications such as composites, specialty chemicals and biodegradable polymers.
Thirumalai Chemicals Limited’s subsidiary, TCL Specialties LLC, has initiated pre-commissioning and startup activities at its new West Virginia facility. The facility, which includes a Maleic Anhydride plant and a Food Ingredients plant, aims to address underserved markets in the US and reduce reliance on imports. The strategic location in the Marcellus-Utica shale region and the use of proprietary technologies promise cost efficiency and environmental benefits, aligning with the US’s push for domestic manufacturing.
Thirumalai Chemicals Limited announced that its step-down subsidiary, Optimistic Organic Sdn Bhd (OOSB) in Malaysia, is experiencing a prolonged outage in its Maleic Anhydride unit due to machinery failure. This outage is expected to reduce the company’s consolidated revenue by INR 235 crore annually, impacting 9.6% of its FY25 revenue. The company is actively seeking solutions to restore operations, although the financial impact remains significant.
Thirumalai Chemicals Limited announced the results of a postal ballot, where a special resolution to issue equity shares through a preferential issue on a private placement basis was overwhelmingly approved by shareholders. This move is likely to strengthen the company’s financial position and enhance its market presence, signaling a positive outlook for stakeholders.
Thirumalai Chemicals Limited has announced the completion of dispatching the Notice of Postal Ballot to its members, as published in prominent newspapers. The company is seeking approval for a special resolution to issue equity shares through a preferential issue on a private placement basis. This move is part of the company’s strategic efforts to raise capital and enhance its financial positioning, potentially impacting its market standing and providing opportunities for investors.
Thirumalai Chemicals Limited has announced a postal ballot seeking shareholder approval for a special resolution to issue equity shares through a preferential issue on a private placement basis. This move is part of the company’s strategy to raise capital, potentially impacting its market positioning by enhancing its financial resources for growth and expansion.
Thirumalai Chemicals Limited has submitted a confirmation certificate to the stock exchanges in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate confirms that the securities received for dematerialization during the quarter ended September 30, 2025, have been processed and listed on the relevant stock exchanges. This compliance ensures the company’s adherence to regulatory requirements, potentially strengthening its market position and maintaining trust with stakeholders.